Inhibition of CDK8/CDK19 suppresses its pro-oncogenic effects in prostate cancer. Offermann A, Joerg V, Becker F, Roesch MC, et al. Am J Pathol 2022 Feb 15. pii: S0002-9440(22)00047.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Offermann A, Joerg V, Becker F, Roesch MC, et al. Inhibition of CDK8/CDK19 suppresses its pro-oncogenic effects in prostate cancer. Am J Pathol 2022 Feb 15. pii: S0002-9440(22)00047.
PMID: 35181333